Startup Valuation Methods Explained (2026 Guide)

How startup valuation works

At its absolute core, startup valuation is not an exact science—it is a negotiated number driven by supply and demand. When more investors want to invest than the founder is willing to sell equity for, the valuation prices upward. When a founder is desperate for cash and growth is stalling, the valuation plummets. In early-stage venture capital, a valuation is a mechanism to determine how much of the company an investor will own (typically 15% to 25% per round) in exchange for the capital required to reach the next major milestone. A founder seeking to estimate startup value must align their capital requirements with acceptable dilution limits rather than obsessing over an objective "true" worth.

Why startup valuation differs from normal businesses

A standard business like a restaurant or consulting agency uses historical revenue and EBITDA (profit) to determine its price tag. If an agency makes $1M in profit, it might sell for $3M (a 3x multiple). Startups, inherently engineered for explosive, exponential growth, often run at a massive unprofitability initially to acquire market share. Therefore, valuing a startup requires throwing out standard EBITDA multiples and instead focusing on potential Total Addressable Market (TAM), intellectual property, team execution capacity, and strategic positioning. Without hard data, investors rely heavily on heuristics. If you have hit massive scale, you should refer to our guide on business valuation multiples to see how late-stage companies are definitively priced.

Pre-revenue valuation methods

How do you assign a multi-million-dollar price tag to three engineers in a garage with a slide deck? You utilize pre-revenue valuation frameworks. Because there are no financial fundamentals to analyze, investors rely on relative proxies of execution risk. They assess the probability of failure at various stages—product development risk, market risk, and team risk—and discount the expected potential upside accordingly. The three most common frameworks utilized by angels and early-stage funds are the Scorecard Method, the Venture Capital Method, and the Berkus Method, which we outline below.

Scorecard valuation method

The Scorecard Method involves comparing the target startup to recently funded, similar startups in the same geographic region and sector. Instead of making blind guesses, investors gather a baseline average pre-money valuation for comparable seed-stage companies (for instance, an average $8M valuation for local AI SaaS startups). Then, the investor adjusts this baseline up or down across a weighted scorecard. If the target startup has a particularly stellar team consisting of second-time founders, the investor might boost that dimension by 130%. If the market size is smaller than average, they might discount that dimension by 80%. The final aggregated score determines the new adjusted valuation relative to the market baseline.

Venture capital method

First articulated by Harvard Business School Professor Bill Sahlman, the Venture Capital method thinks with the end in mind. The investor asks, "What will this company be worth when it goes public or gets acquired?" Let's assume an investor believes a startup will sell for $100M in five years. Since investing in early-stage startups is highly risky, that specific investor demands a 20x return on their investment. To make a 20x return on a $100M exit, they mandate a post-money valuation of $5M today ($100M / 20). If the startup is asking for $1M in funding, the pre-money valuation is set at $4M. This method forces founders and investors to align on the trajectory and scale of the expected exit event.

Berkus valuation method

Dave Berkus developed a simple, highly structured rubric for pre-revenue startups seeking up to $2.5M in funding. The framework assigns an absolute financial value (up to $500k each) across five key risk-reduction dimensions: the validity of the idea (basic value), a quality management team (reduces execution risk), a working prototype (reduces technology risk), high-quality board members or strategic relationships (reduces market risk), and early sales or product rollout (reduces production risk). A startup hitting the maximum score in all five categories would command a $2.5M pre-money valuation. While the standard $500k cap is often adjusted upward significantly in modern macroeconomic environments (to $1M+ per dimension), the core principles of de-risking remain identical.

Market comparison valuation

Often referred to as "Comp Analysis," this is essentially the real estate approach applied to software. Investors find three to five extremely similar startups that recently raised capital or got acquired, and map out their operating metrics. If a comparable competitor was generating $2M in ARR with a 70% gross margin and raised an $18M Series A at a $100M valuation (a 50x multiple), an investor might apply a heavily discounted version of that multiple to your earlier-stage metrics. Market comparisons anchor expectations, which is why founders aggressively seek to position their companies in the hottest current technology trends (like Web3 in 2021, and Generative AI from 2023 onward) to benefit from artificially inflated peer comparables.

Investor expectations

Understand this: professional venture capitalists assume 80% to 90% of their startup investments will go to zero. They do not invest for a safe 2x return. They need the 10% of companies that succeed to return 50x or 100x the initial capital to cover the tremendous losses of the rest of the portfolio. Consequently, your valuation is heavily indexed on your ability to convince them that your market is large enough to sustain a billion-dollar outcome. If your total addressable market limits your revenue ceiling to $20M a year, your business is a fantastic cash-flowing asset, but fundamentally un-backable by traditional institutional venture capital.

Real world startup valuation example

Let's consider "Atlas Health," an unlaunched B2B SaaS platform for hospital administration. The founders (one exited CTO, one former hospital administrator) need $2M to build the product and hire initial sales staff. Because they have a stellar track record (strong Scorecard adjustment), a massive total addressable market, and clear strategic relationships, angels and seed funds are highly interested. They apply the VC Method: expecting the company to reach $5M ARR in 4 years and sell for $50M. Investors demand a 10x return, placing the post-money valuation today at $5M. To raise $2M, they must sell 40% of the company, setting the pre-money valuation at $3M. Understanding this math dynamically prevents founders from over-diluting in early rounds.

Frequently Asked Questions